Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Research

Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine

Authors: Flavia Beccia, Marzia Di Marcantonio, Francesco Andrea Causio, Lena Schleicher, Lili Wang, Chiara Cadeddu, Walter Ricciardi, Stefania Boccia

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

The advent of Personalized Medicine (PM) holds significant promise in revolutionizing healthcare by tailoring treatments to individual patients based on their data. However, its successful implementation requires the seamless integration of innovative technologies and presents formidable challenges in terms of sustainability. To tackle these challenges head-on, the International Consortium for Personalized Medicine (ICPerMed) was established, and the IC2PerMed project, as part of this consortium, seeks to foster collaboration between the European Union (EU) and China in the field of Personalized Medicine. Based on the results collected by the project, the objective of this study is to discern the key priorities for the implementation of Personalised Medicine concerning Information and Communication Technologies (ICT) and Big Data and digital solutions, with a particular emphasis on data management and protection.

Methods

A Delphi survey was conducted to gather expert’s consensus on the main priorities for actions on Information and Communication Technologies (ICT) and Big Data and digital solutions in the field of Personalized Medicine.

Results

The survey identified seven priorities in the area of Big Data and digital solutions, including data interoperability, standards, security measures, and international partnerships. Additionally, twelve priorities were identified for the innovation-to-market process, emphasizing cost-effectiveness, need assessment, and value definition in resource allocation.

Conclusions

The effective implementation of new technologies in Personalized Medicine research and practice is essential for the advancement of healthcare systems in both the European and Chinese contexts. The identified priorities play a pivotal role in promoting the sustainability of health systems and driving innovation in the implementation of Personalized Medicine. Addressing challenges related to data interoperability, standards, security, international collaboration, cost-effectiveness, and value assessment is of utmost importance in order to propel the progress of Personalized Medicine in healthcare systems.
Literature
1.
go back to reference Beccia F, Hoxhaj I, Castagna C, Strohäker T, Cadeddu C, Ricciardi W, et al. An overview of Personalized Medicine landscape and policies in the European Union. Eur J Public Health. 2022;32(6):844–51.CrossRefPubMedPubMedCentral Beccia F, Hoxhaj I, Castagna C, Strohäker T, Cadeddu C, Ricciardi W, et al. An overview of Personalized Medicine landscape and policies in the European Union. Eur J Public Health. 2022;32(6):844–51.CrossRefPubMedPubMedCentral
3.
go back to reference Causio FA, Hoxhaj I, Beccia F, di Marcantonio M, Strohäker T, Cadeddu C, et al. Big data and ICT solutions in the European Union and in China: A comparative analysis of policies in personalized medicine. Digit Health. 2022;8:20552076221129060.PubMedPubMedCentral Causio FA, Hoxhaj I, Beccia F, di Marcantonio M, Strohäker T, Cadeddu C, et al. Big data and ICT solutions in the European Union and in China: A comparative analysis of policies in personalized medicine. Digit Health. 2022;8:20552076221129060.PubMedPubMedCentral
4.
go back to reference Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262–73.CrossRefPubMed Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262–73.CrossRefPubMed
7.
go back to reference Morsella A, Cadeddu C, Castagna C, Hoxhaj I, Sassano M, Wang CM, et al. ‘Integrating China in the International Consortium for Personalized Medicine’: The Coordination and Support Action to Foster Collaboration in Personalized Medicine Development between Europe and China. Public Health Genomics. 2021;24(5–6):310–4.CrossRefPubMed Morsella A, Cadeddu C, Castagna C, Hoxhaj I, Sassano M, Wang CM, et al. ‘Integrating China in the International Consortium for Personalized Medicine’: The Coordination and Support Action to Foster Collaboration in Personalized Medicine Development between Europe and China. Public Health Genomics. 2021;24(5–6):310–4.CrossRefPubMed
8.
go back to reference Tan X, Zhang Y, Shao H. Healthy China 2030, a breakthrough for improving health. Glob Health Promot. 2019;26(4):96–9.CrossRefPubMed Tan X, Zhang Y, Shao H. Healthy China 2030, a breakthrough for improving health. Glob Health Promot. 2019;26(4):96–9.CrossRefPubMed
9.
go back to reference Beccia F, Causio FA, Hoxhaj I, Huang HY, Wang L, Wang W, et al. Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals’ education and citizens’ empowerment in personalised medicine. BMC Med Educ. 2023;23(1):438.CrossRefPubMedPubMedCentral Beccia F, Causio FA, Hoxhaj I, Huang HY, Wang L, Wang W, et al. Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals’ education and citizens’ empowerment in personalised medicine. BMC Med Educ. 2023;23(1):438.CrossRefPubMedPubMedCentral
10.
go back to reference Hoxhaj I, Beccia F, Morsella A, Cadeddu C, Ricciardi W, Boccia S. A survey of experts on personalized medicine landscape in European Union and China. BMC Health Serv Res. 2023;23(1):517.CrossRefPubMedPubMedCentral Hoxhaj I, Beccia F, Morsella A, Cadeddu C, Ricciardi W, Boccia S. A survey of experts on personalized medicine landscape in European Union and China. BMC Health Serv Res. 2023;23(1):517.CrossRefPubMedPubMedCentral
12.
go back to reference Harzing AW. Cross-National Industrial Mail Surveys: Why Do Response Rates Differ between Countries? Ind Mark Manag. 2000;29(3):243–54.CrossRef Harzing AW. Cross-National Industrial Mail Surveys: Why Do Response Rates Differ between Countries? Ind Mark Manag. 2000;29(3):243–54.CrossRef
14.
go back to reference Niederberger M, Köberich S, members of the DeWiss Network. Coming to consensus: the Delphi technique. Eur J Cardiovasc Nurs. 2021;20(7):692–5.CrossRefPubMed Niederberger M, Köberich S, members of the DeWiss Network. Coming to consensus: the Delphi technique. Eur J Cardiovasc Nurs. 2021;20(7):692–5.CrossRefPubMed
16.
go back to reference Zaçe D, Hoxhaj I, Pasciuto T, Diakanthos M, Beccia F, Di Pietro ML, et al. The Development and Validation of a Questionnaire to Investigate the Association Between Maternal Food Insecurity and Fetal Structural Anomalies: Delphi Procedure and Pilot Study. Matern Child Health J. 2023;27(9):1518–28.CrossRefPubMedPubMedCentral Zaçe D, Hoxhaj I, Pasciuto T, Diakanthos M, Beccia F, Di Pietro ML, et al. The Development and Validation of a Questionnaire to Investigate the Association Between Maternal Food Insecurity and Fetal Structural Anomalies: Delphi Procedure and Pilot Study. Matern Child Health J. 2023;27(9):1518–28.CrossRefPubMedPubMedCentral
17.
go back to reference Taylor E. We Agree, Don’t We? The Delphi Method for Health Environments Research. HERD Health Environ Res Des J. 2020;13(1):11–23.CrossRef Taylor E. We Agree, Don’t We? The Delphi Method for Health Environments Research. HERD Health Environ Res Des J. 2020;13(1):11–23.CrossRef
18.
go back to reference Stewart D, Gibson-Smith K, MacLure K, Mair A, Alonso A, Codina C, et al. A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people. PLoS ONE. 2017;12(11):e0188348.CrossRefPubMedPubMedCentral Stewart D, Gibson-Smith K, MacLure K, Mair A, Alonso A, Codina C, et al. A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people. PLoS ONE. 2017;12(11):e0188348.CrossRefPubMedPubMedCentral
19.
go back to reference Beiderbeck D, Frevel N, von der Gracht HA, Schmidt SL, Schweitzer VM. Preparing, conducting, and analyzing Delphi surveys: Cross-disciplinary practices, new directions, and advancements. MethodsX. 2021;1(8):101401.CrossRef Beiderbeck D, Frevel N, von der Gracht HA, Schmidt SL, Schweitzer VM. Preparing, conducting, and analyzing Delphi surveys: Cross-disciplinary practices, new directions, and advancements. MethodsX. 2021;1(8):101401.CrossRef
20.
go back to reference Tolsgaard MG, Todsen T, Sorensen JL, Ringsted C, Lorentzen T, Ottesen B, et al. International multispecialty consensus on how to evaluate ultrasound competence: a Delphi consensus survey. PLoS ONE. 2013;8(2):e57687.CrossRefPubMedPubMedCentralADS Tolsgaard MG, Todsen T, Sorensen JL, Ringsted C, Lorentzen T, Ottesen B, et al. International multispecialty consensus on how to evaluate ultrasound competence: a Delphi consensus survey. PLoS ONE. 2013;8(2):e57687.CrossRefPubMedPubMedCentralADS
21.
go back to reference Pastorino R, De Vito C, Migliara G, Glocker K, Binenbaum I, Ricciardi W, et al. Benefits and challenges of Big Data in healthcare: an overview of the European initiatives. Eur J Public Health. 2019;29(Supplement_3):23–7.CrossRefPubMedPubMedCentral Pastorino R, De Vito C, Migliara G, Glocker K, Binenbaum I, Ricciardi W, et al. Benefits and challenges of Big Data in healthcare: an overview of the European initiatives. Eur J Public Health. 2019;29(Supplement_3):23–7.CrossRefPubMedPubMedCentral
24.
go back to reference Chen Y, Song L. China: concurring regulation of cross-border genomic data sharing for statist control and individual protection. Hum Genet. 2018;137(8):605–15.CrossRefPubMedPubMedCentral Chen Y, Song L. China: concurring regulation of cross-border genomic data sharing for statist control and individual protection. Hum Genet. 2018;137(8):605–15.CrossRefPubMedPubMedCentral
25.
go back to reference Mayer-Schönberger V, Ingelsson E. Big Data and medicine: a big deal? J Intern Med. 2018;283(5):418–29.CrossRefPubMed Mayer-Schönberger V, Ingelsson E. Big Data and medicine: a big deal? J Intern Med. 2018;283(5):418–29.CrossRefPubMed
32.
go back to reference Trombert-Paviot B, Rodrigues JM, Rogers JE, Baud R, van der Haring E, Rassinoux AM, et al. GALEN: a third generation terminology tool to support a multipurpose national coding system for surgical procedures. Int J Med Inf. 2000;58–59:71–85.CrossRef Trombert-Paviot B, Rodrigues JM, Rogers JE, Baud R, van der Haring E, Rassinoux AM, et al. GALEN: a third generation terminology tool to support a multipurpose national coding system for surgical procedures. Int J Med Inf. 2000;58–59:71–85.CrossRef
33.
go back to reference Zhang L, Wang H, Li Q, Zhao MH, Zhan QM. Big data and medical research in China. BMJ. 2018;5(360):j5910.CrossRef Zhang L, Wang H, Li Q, Zhao MH, Zhan QM. Big data and medical research in China. BMJ. 2018;5(360):j5910.CrossRef
34.
go back to reference Romagnuolo I, Mariut C, Mazzoni A, de Santis G, Moltzen E, Ballensiefen W, et al. Sino-European science and technology collaboration on personalized medicine: overview, trends and future perspectives. Pers Med. 2021;18(5):455–70. Romagnuolo I, Mariut C, Mazzoni A, de Santis G, Moltzen E, Ballensiefen W, et al. Sino-European science and technology collaboration on personalized medicine: overview, trends and future perspectives. Pers Med. 2021;18(5):455–70.
35.
go back to reference Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. Precision Medicine, AI, and the Future of Personalized Health Care. Clin Transl Sci. 2021;14(1):86–93.CrossRefPubMed Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. Precision Medicine, AI, and the Future of Personalized Health Care. Clin Transl Sci. 2021;14(1):86–93.CrossRefPubMed
Metadata
Title
Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine
Authors
Flavia Beccia
Marzia Di Marcantonio
Francesco Andrea Causio
Lena Schleicher
Lili Wang
Chiara Cadeddu
Walter Ricciardi
Stefania Boccia
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18009-8

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue